315 related articles for article (PubMed ID: 29458390)
21. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression.
Ward KK; Tancioni I; Lawson C; Miller NL; Jean C; Chen XL; Uryu S; Kim J; Tarin D; Stupack DG; Plaxe SC; Schlaepfer DD
Clin Exp Metastasis; 2013 Jun; 30(5):579-94. PubMed ID: 23275034
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
Zhang L; Zou W
Mol Med Rep; 2015 Dec; 12(6):7869-76. PubMed ID: 26497667
[TBL] [Abstract][Full Text] [Related]
24. MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway.
Chen CH; Shyu MK; Wang SW; Chou CH; Huang MJ; Lin TC; Chen ST; Lin HH; Huang MC
Gynecol Oncol; 2016 Jan; 140(1):131-7. PubMed ID: 26616226
[TBL] [Abstract][Full Text] [Related]
25. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
Yousif NG
Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
[TBL] [Abstract][Full Text] [Related]
26. The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.
Ungewiss C; Rizvi ZH; Roybal JD; Peng DH; Gold KA; Shin DH; Creighton CJ; Gibbons DL
Sci Rep; 2016 Jan; 6():18652. PubMed ID: 26728244
[TBL] [Abstract][Full Text] [Related]
27. CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway.
Zhang M; Zhao L
DNA Cell Biol; 2017 Nov; 36(11):983-990. PubMed ID: 28933561
[TBL] [Abstract][Full Text] [Related]
28. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage.
Provenzano PP; Inman DR; Eliceiri KW; Keely PJ
Oncogene; 2009 Dec; 28(49):4326-43. PubMed ID: 19826415
[TBL] [Abstract][Full Text] [Related]
29. TNF-α stimulates MMP-2 and MMP-9 activities in human corneal epithelial cells via the activation of FAK/ERK signaling.
Yang YN; Wang F; Zhou W; Wu ZQ; Xing YQ
Ophthalmic Res; 2012; 48(4):165-70. PubMed ID: 22710949
[TBL] [Abstract][Full Text] [Related]
30. Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts.
Geletu M; Adan H; Niit M; Arulanandam R; Carefoot E; Hoskin V; Sina D; Elliott B; Gunning P; Raptis L
Exp Cell Res; 2021 Jul; 404(1):112601. PubMed ID: 33957118
[TBL] [Abstract][Full Text] [Related]
31. ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.
Tumbarello DA; Temple J; Brenton JD
Mol Cancer; 2012 May; 11():36. PubMed ID: 22640878
[TBL] [Abstract][Full Text] [Related]
32. Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway.
Sun X; Lin L; Chen Y; Liu T; Liu R; Wang Z; Mou K; Xu J; Li B; Song H
Mol Med Rep; 2016 Apr; 13(4):3161-8. PubMed ID: 26935265
[TBL] [Abstract][Full Text] [Related]
33. IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.
Fujisawa T; Joshi BH; Puri RK
Int J Cancer; 2012 Jul; 131(2):344-56. PubMed ID: 21858811
[TBL] [Abstract][Full Text] [Related]
34. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
35. HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase.
Selvendiran K; Ahmed S; Dayton A; Ravi Y; Kuppusamy ML; Bratasz A; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Mol Cancer Res; 2010 Sep; 8(9):1188-97. PubMed ID: 20713491
[TBL] [Abstract][Full Text] [Related]
36. 2,3,7,8-tetrachlorodibenzo-p-dioxin and epidermal growth factor cooperatively suppress peroxisome proliferator-activated receptor-gamma1 stimulation and restore focal adhesion complexes during adipogenesis: selective contributions of Src, Rho, and Erk distinguish these overlapping processes in C3H10T1/2 cells.
Liu X; Jefcoate C
Mol Pharmacol; 2006 Dec; 70(6):1902-15. PubMed ID: 16971554
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
38. Integrins induce expression of monocyte chemoattractant protein-1 via focal adhesion kinase in mesangial cells.
Watanabe Y; Tamura M; Osajima A; Anai H; Kabashima N; Serino R; Nakashima Y
Kidney Int; 2003 Aug; 64(2):431-40. PubMed ID: 12846738
[TBL] [Abstract][Full Text] [Related]
39. Signal transduction by focal adhesion kinase in cancer.
Zhao J; Guan JL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
[TBL] [Abstract][Full Text] [Related]
40. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
